Fgfr1 - fibroblast growth factor receptor 1 Gene

Mus musculus

Also known as FLG; Fr1; MFR; Eask; Hspy; Flt-2; c-fgr; FGFR-I; Fgfr-1; bFGF-R-1

Gene ID: 14182 | Gene type: protein coding

About Fgfr1

Chromosome 8: 26,003,670-26,065,734 forward strand.GRCm39:CM001001.3

This gene has 19 transcripts (splice variants), 293 orthologues, 53 paralogues and is associated with 206 phenotypes. Broad expression in limb E14.5 (RPKM 38.2), adrenal adult (RPKM 35.4) and 23 other tissues.

Summary

Enables SH2 domain binding activity; Fibroblast Growth Factor binding activity; and fibroblast growth factor-activated receptor activity. Involved in forebrain development; negative regulation of transcription by RNA polymerase II; and positive regulation of cell cycle. Acts upstream of or within several processes, including animal organ development; positive regulation of cell population proliferation; and regulation of animal organ morphogenesis. Located in plasma membrane. Is expressed in several structures, including alimentary system; central nervous system; embryo mesenchyme; genitourinary system; and sensory organ. Used to study Pfeiffer syndrome and otitis media. Human ortholog(s) of this gene implicated in several diseases, including Jackson-Weiss syndrome; bone disease (multiple); cleft lip; hematologic Cancer (multiple); and hypogonadotropic hypogonadism (multiple). Orthologous to human FGFR1 (Fibroblast Growth Factor receptor 1). [provided by Alliance of Genome Resources, Apr 2022]

Fgfr1 Products(3)

mRNA	Protein	Name
NM_001079908.3	NP_001073377.1	fibroblast growth factor receptor 1 isoform 2 precursor
NM_010206.4	NP_034336.2	fibroblast growth factor receptor 1 isoform 1 precursor
NM_001079909.3	NP_001073378.1	fibroblast growth factor receptor 1 isoform 3 precursor

Fgfr1 Protein Structure

IgI_1_FGFR

IgI_2_FGFR

PTKc_FGFR1

0
200
400
600
822 a.a.

Protein Preferred Names

Protein Names

fibroblast growth factor receptor 1

basic fibroblast growth factor receptor 1

proto-oncogene c-Fgr

Recombinant Fgfr1 Proteins

Cat. No.	Product Name	Accession	Purity
HY-P75767	FGFR-1 Protein, Mouse (HEK293, Fc)	P16092 (M1-E376)	≥95%
HY-P75768	FGFR-1 Protein, Mouse (HEK293, His)	P16092 (R22-E376)	≥95%

Related Agents

Approval

Bioactive Molecules (15)

Cat. No.	Product Name	Effect	Purity	Rare Diseases
HY-10981	Lenvatinib	Inhibitor	99.84%	Yes
HY-50904	Nintedanib	Inhibitor	99.94%	Yes
HY-12047	Ponatinib	Inhibitor	99.43%	Yes
HY-18708	Erdafitinib	Inhibitor	99.66%	Unkown
HY-13311	Infigratinib	Inhibitor	99.72%	Yes
HY-109099	Pemigatinib	Inhibitor	99.73%	Yes
HY-10208	Pazopanib	Inhibitor	99.91%	Yes
HY-100818	Futibatinib	Inhibitor	99.65%	Unkown
HY-11106	Nintedanib esylate	Inhibitor	99.95%	Yes
HY-10981A	Lenvatinib mesylate	Inhibitor	99.86%	Yes
HY-N0060	Ferulic acid	Inhibitor	99.87%	Yes
HY-12009	Pazopanib Hydrochloride	Inhibitor	99.88%	Yes
HY-12297	Sulfatinib	Inhibitor	98.65%	Unkown
HY-108766	Ponatinib hydrochloride	Inhibitor	99.55%	Yes
HY-13311A	Infigratinib phosphate	Inhibitor	99.74%	Yes

Clinical Phase

Bioactive Molecules (20)

Cat. No.	Product Name	Effect	Purity	Phase
HY-13330	Fexagratinib	Inhibitor	99.85%	Phase 3
HY-50905	Dovitinib	Inhibitor	99.94%	Phase 3
HY-100019	Rogaratinib	Inhibitor	99.86%	Phase 3
HY-10517	Orantinib	Inhibitor	99.21%	Phase 3
HY-15391	Lucitanib	Inhibitor	98.94%	Phase 3
HY-10207	Dovitinib lactate	Inhibitor	99.62%	Phase 3
HY-B0062	Dovitinib lactate hydrate	Inhibitor	/	Phase 3
HY-101568	Roblitinib	Inhibitor	99.74%	Phase 2
HY-10987A	ENMD-2076	Inhibitor	99.12%	Phase 2
HY-19957	Zoligratinib	Inhibitor	99.76%	Phase 2
HY-19981	Derazantinib	Inhibitor	99.28%	Phase 2
HY-10987	ENMD-2076 Tartrate	Inhibitor	99.42%	Phase 2
HY-10186	TG 100801	Inhibitor	98.60%	Phase 2
HY-101466A	E7090 succinate	Inhibitor	99.17%	Phase 2
HY-10187	TG 100801 Hydrochloride	Inhibitor	/	Phase 2
HY-10339	KW-2449	Inhibitor	99.69%	Phase 1
HY-13304	LY2874455	Inhibitor	98.03%	Phase 1
HY-119367	ODM-203	Inhibitor	99.91%	Phase 1
HY-19983	ASP5878	Inhibitor	99.86%	Phase 1
HY-101768	PRN1371	Inhibitor	99.43%	Phase 1

Inhibitory Antibodies (1)

Cat. No.	Product Name	Effect	Purity	Phase
HY-P99614	Fazpilodemab	Agonist	99.00%	Phase 2

Pre-clinical Phase

Bioactive Molecules (39)

Cat. No.	Product Name	Effect	Purity	Rare Diseases
HY-10321	PD173074	Inhibitor	99.70%	Unkown
HY-10407	SU 5402	Inhibitor	99.38%	Unkown
HY-101296	PD-166866	Inhibitor	99.89%	Unkown
HY-12823	BLU9931	Inhibitor	99.95%	Unkown
HY-15599	SSR128129E	Inhibitor	99.85%	Unkown
HY-18602	FIIN-2	Inhibitor	99.63%	Unkown
HY-145231	FGFR2-IN-2	Inhibitor	98.09%	Unkown
HY-10185	TG 100572 Hydrochloride	Inhibitor	98.96%	Unkown
HY-148779	FGFR3-IN-5	Inhibitor	99.28%	Unkown
HY-114311	FGFR1/DDR2 inhibitor 1	Inhibitor	98.26%	Unkown
HY-100315	Tyrosine kinase-IN-1	Inhibitor	99.34%	Unkown
HY-131908	CPL304110	Inhibitor	99.68%	Unkown
HY-101466	E7090	Inhibitor	99.64%	Unkown
HY-13737	R1530	Inhibitor	99.06%	Unkown
HY-15813	FIIN-1	Inhibitor	99.11%	Unkown
HY-16025	EOC317	Inhibitor	98.05%	Unkown
HY-100491	H3B-6527	Inhibitor	≥98.0%	Unkown
HY-12965	S49076	Inhibitor	99.71%	Unkown
HY-118203	SU4984	Inhibitor	99.14%	Unkown
HY-156019	FGFR1 inhibitor-10	Inhibitor	98.92%	Unkown
HY-112345	PD-089828	Inhibitor	98.07%	Unkown
HY-18603	FIIN-3	Inhibitor	99.66%	Unkown
HY-108933	JK-P3	Inhibitor	99.72%	Unkown
HY-10517A	(Z)-Orantinib	Inhibitor	99.02%	Unkown
HY-10184	TG 100572	Inhibitor	/	Unkown
HY-151903S	FGFR2/3-IN-1	Inhibitor	/	Unkown
HY-101544	ARQ 069	Inhibitor	/	Unkown
HY-139376	FGFR1 inhibitor-2	Inhibitor	/	Unkown
HY-143272	FGFR1 inhibitor-6	Inhibitor	/	Unkown
HY-147715	FGFR3-IN-3	Inhibitor	/	Unkown
HY-150652	FGFR-IN-8	Inhibitor	/	Unkown
HY-152104	FGFR-IN-9	Inhibitor	/	Unkown
HY-155028	FGFR-IN-11	Inhibitor	/	Unkown
HY-147713	FGFR3-IN-1	Inhibitor	/	Unkown
HY-150026	Multi-kinase-IN-2	Inhibitor	/	Unkown
HY-152146	HDAC-IN-50	Inhibitor	/	Unkown
HY-149415	Multi-kinase-IN-5	Inhibitor	/	Unkown
HY-142921	FGFR-IN-2	Inhibitor	/	Unkown
HY-15599A	SSR128129E free acid	Inhibitor	/	Unkown

Orthologs Information

Species	Symbol	Source	ID
Homo sapiens	Fgfr1	NCBI	NCBI:2260

Name
Email *

	Sorry, but the email address you supplied was invalid.